XML 39 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES      
Income (loss) from continuing operations R$ (1,868,852) R$ (3,090,678) R$ 517,314
Adjustments for:      
Depreciation and amortization 1,834,232 1,777,703 1,715,863
Depreciation and depletion of biological assets 1,390,550 1,214,002 1,030,491
Result on disposal of property, plant and equipments and intangible (63,229) 3,985 (141,211)
Write-down of inventories to net realizable value (96,094) 56,337 128,680
Provision for tax, civil and labor risks 271,063 341,038 116,144
Income from investments under the equity method 3,264 (1,076)
Financial results, net 2,820,850 2,668,755 3,044,575
Tax recoveries and gains in tax lawsuits (173,404) (39,547) (108,785)
Deferred income tax (244,172) 208,060 (807,744)
Employee profit sharing 173,064 (10,190) 170,425
Gratuities for the employees 108,803
Other provisions [1] (172,117) 554,460 2,793
 Cash flow provided by operating activities before working capital 3,983,958 3,682,849 5,668,545
Changes in assets and liabilities:      
Trade accounts and notes receivables (606,550) (144,597) 386,889
Inventories 1,961,810 712,913 (2,878,507)
Biological assets - current 385,027 (296,934) (815,699)
Trade accounts payable (3,295,127) (1,366,667) 2,210,960
Cash generated by operating activities 2,429,118 2,587,564 4,572,188
Redemptions (investments) in securities at FVTPL [2] 18,768 4,093 30,012
Interest received 455,827 281,989 106,388
Dividends and interest on shareholders' equity received (851)
Payment of tax, civil and labor provisions (397,872) (292,385) (399,252)
Derivative financial instruments (237,773) (1,191,475) 266,491
Other operating assets and liabilities 1,672,180 486,598 (652,191)
Net cash provided by operating activities 3,939,397 1,876,384 3,923,636
CASH FLOWS FROM INVESTING ACTIVITIES      
Redemption (additions) on investments in securities at amortized cost (60,711) 1,111 162,052
Redemption (additions) on investments in securities at FVTOCI [3] 73,193
Redemption of restricted cash 12,851 (2,074) 400
Additions to property, plant and equipment (791,817) (1,452,733) (1,555,426)
Additions to biological assets - non-current (1,457,174) (1,387,669) (1,239,746)
Proceeds from disposals of property, plant, equipments and investment 167,704 62,545 58,836
Additions to intangible assets (167,601) (228,734) (179,632)
Business combination, net of cash (158,348) (985,639)
Sale of participation in subsidiaries with loss of control 132,951
Capital increase in affiliates (768) (92,885) 1,770
Capital increase in subsidiaries 183,672
Net cash used in investing activities (2,113,844) (3,258,787) (3,531,241)
Net cash used in investing activities from discontinued operations (17,550)
Net cash used in investing activities (2,113,844) (3,258,787) (3,548,791)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from debt issuance 3,836,483 3,392,613 2,990,782
Repayment of debt (6,889,936) (3,984,422) (1,395,347)
Payment of interest (1,679,825) (1,518,301) (1,193,367)
Payment of interest derivatives - fair value hedge (699,345) (252,662) (2,975)
Capital increase through issuance of shares 5,313,241 5,275,444
Treasury shares acquisition (27,721)
Acquisition of non-controlling interests (7,288) (238,421)
Payment of lease liabilities (742,455) (649,846) (705,427)
Net cash provided (used in) by financing activities (861,837) 2,255,538 (572,476)
Effect of exchange rate variation on cash and cash equivalents 170,019 (271,026) 149,826
Net increase (decrease) in cash and cash equivalents 1,133,735 602,109 (47,805)
Balance at the beginning of the year 8,130,929 7,528,820 7,576,625
Balance at the end of the year R$ 9,264,664 R$ 8,130,929 R$ 7,528,820
[1] In 2022 includes the amount of R$583,977 relating to the Leniency Agreement (note 1.2) and R$4,797 related to other expenses related to investigations.
[2] FVTPL: Fair Value Through Profit and Loss.
[3] FVTOCI: Fair Value Through Other Comprehensive Income.